Download | < Back |
24 Mar 2017 | |
Dear Sirs, We are pleased to enclose herewith our Press Release relating to Regulatory Filing of Tildrakizumab in Europe, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |